RE: Bullish23 May 2025 17:33
If we take DD, then FY24: Revenue £10,790. Cost of sales £10,941. Gross loss of £151. Note that this before the subtraction of £1,386 of DD admin costs.
Revenue for DD should be comfortably £15-20m FY25. Just to make sure I'm understanding you correctly, what you're saying is that cost of sales can be expected not increase as much as revenue?
Cost of sales would include the cost of goods, warehousing and delivery costs (plus anything I've missed). If we take this one by one:
(1) cost of goods: likely to track revenue with perhaps a small improvement from buying in greater quantity
(2) warehousing: likely to not increase much as higher revenues can be currently mostly served by existing capacity, increasing warehouse efficiencies and AOVs should increased
(3) delivery: likely to increase due to increase deliveries, but not as much as revenue due to efficiencies in pallet organisation and increases in AOV.
It's difficult to get an idea of how their costs are evolving. If we know what percentage of their cost of sales equates to buying goods to sell (pre-warehouse and delivery), then we can a better idea of the viability of the business model. It would be useful to have a breakdown of the cost of sales, however this may make it more difficult to negotiate when buying goods (if the seller knows how margin they're giving away they may demand more). This would be like figuring out what their "gross gross margin" (that was gross twice), i.e. purely how much margin, pre-all other costs incl. warehouse and delivery, do they have on products they buy for DD, Boop and Nutricircle. There is likely to be wide variation both between and within each brand.
I note that Motatos was heavily loss making. I'm very much in favour of management's approach of steady, controlled, "operationally profitable" growth. Once they achieve positive cash flow, then I am sure they will continue to optimise profitability and growth. There is a mathematical attraction to understanding this business (because both supply and demand are both established, and the company is not supply constrainted - only purposefully demand constrained by capacity).
Share price catalysts: continued growth, xmas period blow out growth, FY25 cash flow positive, reiteration of no need for dilutitive equity raise, sales of Boop and Nutricircle into Europe, FY26 continued growth, improving margins. I don't like to value on a sales multiple basis, but difficult at present to value on any other basis. FY25 sales of £20m-30m, apply a 1x multiple (assume cash flow positive), then this is a 2-3x within 12 months.